NEUROFILAMENT LIGHT PROTEIN AS A BIOMARKER FOR HUNTINGTON'S DISEASE

被引：0
|
作者：
Lauren, Byrne [1 ,2 ]
Filipe, Rodrigues [1 ,2 ]
Eileanoir, Johnson [1 ]
Rana, Solyu Kucharz [3 ]
Sarah, Gregory [1 ]
Rachael, Scahill [1 ]
Maria, Bjorkqvist [3 ]
Henrik, Zetterberg [3 ,4 ,5 ]
Sarah, Tabrizi [1 ,2 ]
Edward, Wild [1 ,2 ]
机构：
[1] UCL, Inst Neurol, UCL Huntingtons Dis Ctr, London, England
[2] Natl Hosp Neurol & Neurosurg, Queen Sq, London, England
[3] Lund Univ, Wallenberg Neurosci Ctr, Lund, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden
[5] UK Dementia Res Inst, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2018年 / 89卷 / 10期
关键词：
D O I：
10.1136/jnnp-2018-ABN.158
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
294
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neurofilament Light Protein in Blood as a Biomarker of Neurodegeneration in Huntington's Disease
    Wild, Edward J.
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Blennow, Kaj
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A. C.
    Scahill, Rachael I.
    Tabrizi, Sarah J.
    Zetterberg, Henrik
    Langbehn, Douglas
    ANNALS OF NEUROLOGY, 2017, 82 : S187 - S187
  • [2] Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children
    Byrne, Lauren M.
    Schultz, Jordan L.
    Rodrigues, Filipe B.
    van Der Plas, Ellen
    Langbehn, Douglas
    Nopoulos, Peggy C.
    Wild, Edward J.
    MOVEMENT DISORDERS, 2022, 37 (07) : 1526 - 1531
  • [3] Neurofilament light protein: An emerging clinical and translational biofluid biomarker for Huntington's disease
    Byrne, L.
    Rodrigues, F.
    Johnson, E.
    Gregory, S.
    Kucharz, R. Soylu
    Bjorkqvist, M.
    Heslegrave, A.
    Blennow, K.
    Durr, A.
    Leavitt, B.
    Roos, R.
    Tabrizi, S.
    Zetterberg, H.
    Langbehn, D.
    Scahill, R.
    Wild, E.
    MOVEMENT DISORDERS, 2018, 33 : S377 - S378
  • [4] Neurofilament Light Protein as a Blood-Based Biomarker for Juvenile-Onset Huntington's Disease
    Byrne, Lauren
    Schultz, Jordan L.
    Rodrigues, Filipe B.
    van der Plas, Ellen
    Langbehn, Douglas
    Nopoulous, Peggy C.
    Wild, Edward J.
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 24 - 24
  • [5] Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Blennow, Kaj
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A. C.
    Scahill, Rachael I.
    Tabrizi, Sarah J.
    Zetterberg, Henrik
    Langbehn, Douglas
    Wild, Edward J.
    LANCET NEUROLOGY, 2017, 16 (08): : 601 - 609
  • [6] Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
    Niemela, Valter
    Landtblom, Anne-Marie
    Blennow, Kaj
    Sundblom, Jimmy
    PLOS ONE, 2017, 12 (02):
  • [7] Application Value of Serum Neurofilament Light Protein for Disease Staging in Huntington's Disease
    Li, Xiao-Yan
    Bao, Yu-Feng
    Xie, Juan-Juan
    Gao, Bin
    Qian, Shu-Xia
    Dong, Yi
    Wu, Zhi-Ying
    MOVEMENT DISORDERS, 2023, 38 (07) : 1307 - 1315
  • [8] The relationship between lifestyle and serum neurofilament light protein in Huntington's disease
    Cruickshank, Travis
    Bartlett, Danielle
    Govus, Andrew
    Hannan, Anthony
    Teo, Wei-Peng
    Mason, Sarah
    Lo, Johnny
    Ziman, Mel
    BRAIN AND BEHAVIOR, 2020, 10 (05):
  • [9] NEUROFILAMENT LIGHT PROTEIN IN BLOOD PREDICTS REGIONAL ATROPHY IN HUNTINGTON'S DISEASE
    Scahill, Rachael I.
    Johnson, Eileanoir B.
    Byrne, Lauren
    Gregory, Sarah
    Rodrigues, Filipe B.
    Blennow, Kaj
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A.
    Zetterberg, Henrik
    Tabrizi, Sarah J.
    Wild, Edward J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A34 - A35
  • [10] Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease
    Constantinescu, R.
    Romer, M.
    Rosengren, L.
    Oakes, D.
    Kieburtz, K.
    MOVEMENT DISORDERS, 2007, 22 : S26 - S27
12345